Accordingly, an adiponectin receptor (adipoR1/adipoR2) agonist “AdipoRon”, in clinical tests for Type 2 diabetes, is apparently effective in hepatic AMPK activation and counteraction of insulin resistance24, 68. The gene discussed is INS; the disease is type 2 diabetes mellitus.